Erratum to: hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63 (Journal of Physiology and Biochemistry (2011) DOI: 10.1007/s13105-011-0126-y);hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63: Role of hRpn13 in osteoblasts

Journal of Physiology and Biochemistry

Volumn 68, Issue 1, 2012, Pages 129-139

  Zhao, Xi ^a   Chao, Yonglie ^a   Chen, Pixiu ^a   Tang, Yaxiong ^b   Liu, Die ^a   Su, Peng ^b   Cui, Xuqin ^c  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU INSTITUTE OF BIOLOGY   (China)

^c SOUTHWEST JIAOTONG UNIVERSITY   (China)

Author keywords

Differentiation; hRpn13; Kappa B ligand; MG63; Osteoblast; Osteoprotegerin; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; CYCLINE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SMALL INTERFERING RNA; UBIQUITIN;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; GENE REPRESSION; HRPN13 GENE; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PROTEIN DEGRADATION; UBIQUITIN PROTEASOME SYSTEM;

EID: 84858076026     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-011-0134-y     Document Type: Erratum

References (26)

1. Anandarajah AP, Schwarz EM (2009) Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. Adv Exp Med Biol 649:85-99
2. Ando K, Mori K, Redini F, Heymann D (2008) RANKL/RANK/OPG: key therapeutic target in bone oncology. Curr Drug Discov Technol 5:263-268
3. Barnouti ZP, Owtad P, Shen G, Petocz P, Darendeliler MA (2011) The biological mechanisms of PCNA and BMP in TMJ adaptive remodeling. Angle Orthod 81(1):91-99
4. Boyce BF, Xing L (2008) Functions of RANKL/RANK/ OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139-146
5. Bruhn C (2010) Denosumab. The first inhibitor of RANK-ligand for treatment of osteoporosis. Med Monatsschr Pharm 33:370-375
6. Chen X, Lee B-H, Finley D, Walters KJ (2010) Structure of proteasome ubiquitin receptor hRpn13 and its activation by the scaffolding protein hRpn2. Mol Cell 38(3):404-415
7. Elangovan M, Oh C, Sukumaran L, Wójcik C, Yoo YJ (2011) Functional differences between two major ubiquitin receptors in the proteasome, S5a, and hRpn13. Biochem Biophys Res Commun 396(2):425-428
8. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J, Chen Y, Su H, Young WL, Yang GY (2010) Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 67:488-497
9. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373-428 (Pubitemid 34654457)
10. Glickman MH, Maytal V (2002) Regulating the 26S proteasome. Curr Top Microbiol Immunol 268:43-72 (Pubitemid 34534631)
11. Hamazaki J, Iemura S-I, Natsume T, Yashiroda H, Tanaka K, Murata S (2006) A novel proteasome interacting protein Recruits the deubiquitinating enzyme UCH37 to 26S proteasomes. EMBO J 25:4524-4536 (Pubitemid 44498126)
12. Hartmann-Petersen R, Gordon C (2004) Proteins interacting with the 26S proteasome. Cell Mol Life Sci 61:1589-1595 (Pubitemid 38962041)
13. Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 79:243-253 (Pubitemid 32646379)
14. Hölzl H, Kapelari B, Kellermann J, Seemüller E, Sümegi M, Udvardy A, Medalia O, Sperling J, Müller SA, Engel A (2000) The regulatory complex of Drosophila melanogaster 26S Proteasomes. J Cell Biol 150:119-130
15. Hong YJ, Chun JS, Lee WK (2011) Association of collagen with calcium phosphate promoted osteogenic responses of osteoblast-like MG63 cells. Colloids Surf B Biointerfaces 83:245-253
16. Husnjak K, Elsasser S, Zhang N, Chen X, Randles L, Shi Y, Hofmann K, Walters KJ, Finley D, Dikic I (2008) Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 453:481-488 (Pubitemid 351733317)
17. Kawano M, Ariyoshi W, Iwanaga K, Okinaga T, Habu M, Yoshioka I, Tominaga K, Nishihara T (2011) Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem Biophys Res Commun 405 (4):575-580
18. Kim T, Ha HI, Kim N, Yi O, Lee SH, Choi Y (2009) Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation. Biochem Biophys Res Commun 390:585-590
19. Kostenuik PJ, Shalhoub V (2001) Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des 7:613-635 (Pubitemid 32427765)
20. Lian N,WangW, Li L, Elefteriou F, Yang X (2009) Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J Biol Chem 284(44):30518-30525
21. O'Connell BC, Harper JW (2007) Ubiquitin proteasome system (UPS): what can chromatin do for you? Curr Opin Cell Biol 19:206-214 (Pubitemid 46386410)
22. Qiu XB, Ouyang SY, Li CJ, Miao S, Wang L, Goldberg AL (2006) hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25:5742-5753 (Pubitemid 44967758)
23. Takahashi N, Maeda K, Ishihara A, Uehara S, Kobayashi Y (2011) Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. Front Biosci 16:21-30
24. Tortelli F, Pujic N, Liu Y, Laroche N, Vico L, Cancedda R (2009) Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. Tissue Eng Part A 15:2373-2383
25. Trouvin AP, Goeb V (2010) Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin Interv Aging 5:345-354
26. Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, Chantry A (2005) The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24:8080-8084 (Pubitemid 41746751)